News
On Monday, the U.S. Food and Drug Administration (FDA) approved Amphastar Pharmaceuticals, Inc.’s (NASDAQ:AMPH) Abbreviated ...
Amphastar Pharmaceuticals (AMPH) upgraded to Buy by Needham after FDA approval for generic iron sucrose injection, marking ...
27m
AZoM on MSNSpectrophotometry for Ensuring Natural Sugar Purity
The most common test used by sugar companies, such as American Crystal Sugar, is ICUMSA-420. Producers assign a color value ...
Viatris receives US FDA approval for generic iron sucrose injection to treat IDA in chronic kidney disease: Pittsburgh Tuesday, August 12, 2025, 18:00 Hrs [IST] Viatris Inc., a gl ...
Cognition Therapeutics shares rose 30% pre-market after the FDA confirmed its Phase 3 trial for Alzheimer's drug Zervimesine.
US generics major Viatris has won US Food and Drug Administration (FDA) approval for iron sucrose injection, USP, an ...
23h
TipRanks on MSNAmphastar announced FDA approval of iron sucrose injection
Pharmaceuticals announced yesterday morning that the Food and Drug Administration approved the company’s abbreviated new drug ...
Genshin Impact 6.0 leaks suggest the Nod-Krai region will introduce a unique resonance buff, boosting Lunar Reaction damage ...
Building on their success developing a cleaner way to make valuable organic acids, researchers from the Center for Advanced ...
Westrock Coffee is riding the wave of RTD coffee’s sucess. Last year, it opened North America’s largest ‘roast to ready to ...
23h
TipRanks on MSNNeedham upgrades Amphastar on valuation post AMP-002 approval
Needham upgraded Amphastar (AMPH) (APMH) to Buy from Hold with a $36 price target. The company’s AMP-002 is an iron sucrose injection product that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results